This document relates to continuity monitoring of electrical conductors. For example, this document provides monitors for blood pump systems as well as methods for monitoring continuity of redundant conductors providing power to a blood pump (e.g., an assist device).
Mechanical circulatory support (MCS) is a way of improving blood flow in a failing heart, using an electrically powered blood pump. A ventricular assist device (VAD) is a blood pump that works in conjunction with the recipient's own heart to pump sufficient blood throughout the body. Heart failure may affect the right side of the heart, limiting the ability of the heart to pump blood to the lungs, or the left side of the heart, resulting in an inability to pump sufficient oxygen-rich blood to the rest of the body. A VAD can provide short-term MCS support while a recipient is awaiting cardiac transplant or permanent MCS for a recipient who is not a candidate for transplantation, by delivering consistent blood flow to vital organs.
This document relates to continuity monitoring of electrical conductors. For example, this document provides monitors for blood pump systems as well as methods for monitoring continuity of redundant conductors providing power to a blood pump (e.g., an assist device). In some cases, the methods provided herein can use a knowledge-based evaluation of the integrity of redundant conductors. For example, a monitor provided herein can determine continuity of redundant conductors by testing current in one conductor, comparing the current to a reference value, and determining whether the integrity of redundant conductor has been compromised based on a difference between a test value and a reference value. For example, a blood pump system provided herein can feature streamlined monitoring of redundant conductors for enhanced reliability.
In general, one aspect of this document features a blood pump system that comprises, or consists essentially of, a blood pump, a power supply, a conductor that carries electrical current between the power supply and the blood pump, one or more additional conductors that carry current between the power supply and the blood pump, and a first monitor configured to monitor the conductor and the one or more additional conductors for a failure condition. Monitoring the conductors includes detecting a first electrical current in the conductor and determining whether the failure condition occurred for at least one of the one or more additional conductors, based on the detected electrical current in the conductor. The blood pump system lacks a second monitor configured to detect a second electrical current in at least one of the one or more additional conductors.
The blood pump system can further comprise a controller configured to receive information from the first monitor about the first electrical current in the conductor. The controller can be configured to provide a signal to a user when a change in the first electrical current occurs in the conductor. The controller can be configured to provide information to a user about whether or not the conductor failed. The controller can be configured to provide information to a user about whether or not the one or more of the one or more additional conductors failed. The controller can include a feature for controlling pump speed. The controller can include a built-in rechargeable backup battery and a plurality of power or driveline connectors, which exit the system controller from the same side. The controller can include a visible LED indicator, a built-in LCD display, and a securing device.
In another aspect, this document features a method of monitoring the integrity of a conductor and one or more additional conductors. The conductor and the one or more additional conductors are included in a blood pump system, and the conductor and the one or more additional conductors carry electrical current. The method comprises, or consists essentially of, detecting a change in electrical current in the conductor without monitoring a change in electrical current in one or more of the one or more additional conductors; determining whether the integrity is compromised for at least one of the one or more additional conductors based on the detected electrical current in the conductor; and determining whether the integrity is compromised for the conductor based on the detected electrical current.
In another aspect, this document features a method for monitoring the integrity of a conductor and one or more additional conductors. The conductor and one or more additional conductors are part of a blood pump system and carry electrical current. The method comprises, or consists essentially of, determining a test electrical current in the conductor, while electrical current in one or more of the one or more additional conductors is not determined; comparing the determined test electrical current with a reference that indicates an electrical current that would be present in the conductor if the integrity of the conductor and the integrity of the one or more additional conductors were intact; determining whether the integrity is compromised for at least one of the one or more additional conductors based on the comparison of the determined test electrical current with the reference; and determining whether the integrity is compromised for the conductor based on the comparison of the determined test electrical current with the reference. The reference can comprise a reference electrical current detected in a reference conductor that is a redundant conductor configured to provide supplemental electrical current when the conductor, or at least one of the one or more additional conductors, has compromised integrity. The conductor, the reference conductor, and the one or more additional conductors carry current from a power supply to a blood pump included in the blood pump system. The conductor, the reference conductor, and the one or more additional conductors are configured such that each carries substantially the same electrical current under normal operation of the blood pump system.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Although methods and materials similar or equivalent to those described herein can be used to practice the invention, suitable methods and materials are described below. All publications, patent applications, patents, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.
The details of one or more embodiments of the materials and methods are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
Like reference symbols in the various drawings indicate like elements.
This document relates to continuity monitoring of electrical conductors. For example, this document provides monitors for blood pump systems as well as methods for monitoring continuity of redundant conductors providing power to a device such as a blood pump (e.g., an assist device). For example, a monitor provided herein can determine continuity of redundant conductors by testing current in one conductor, comparing the current to a reference value, and determining whether the integrity of a redundant conductor has been compromised.
The materials and methods described herein can provide continuity monitoring of conductors in any type of cord or cable. In some cases, an electrical cable can house an assembly of two or more conductors. A conductor can be any material that carries electric current. For example, a conductor can be a solid core electrical wire, or an assembly of fine stranded conductors. In some cases, a cable can house a pair of redundant conductors. In some cases, a cable can carry several pairs of redundant conductors. In some cases, a cable can house conductors to carry charge/discharge current, motor current, and other current necessary for operation of a device (e.g., a blood pump system). In some cases, a cable can house three or more groups of redundant conductors.
For example, the materials and methods provided herein can be used with conductors in a power cord that connects an electrically powered device to an electrical outlet, or a power cable that connects an electrically powered device to a battery. In some cases, an electrical cable can connect a VAD system controller to an external power source, such as a battery. In some cases, an electrical cable can be a percutaneous drive-line, connecting a VAD system controller to an implanted heart pump. In some cases, an electrical cable can connect an implanted heart pump directly to an external power supply.
Referring to
Monitor 16 can be configured to detect conductor failure in a pair of redundant conductors by directly monitoring current carried by a single conductor (e.g., conductor 17) and not monitoring the current carried by another conductor in a group conductors (e.g., conductor 15). In some cases, monitor 16 can be configured to monitor a pair of redundant conductors by directly monitoring conductor 15 and not conductor 17. In some cases, monitor 16 can be configured to detect failure in conductors in systems using more than two redundant conductors to ensure system reliability. For example, monitor 16 can detect conductor failures in two, three, four, five, and six redundant conductors, by monitoring a single conductor of the group of conductors.
Conductors 15 and 17 can be a pair of redundant conductors. For example, conductor 15 can be a back-up conductor for conductor 17, and conductor 17 can be a back-up conductor for conductor 15. Conductors 15 and 17 can each carry a share of the electrical current flowing between system components. For example, conductors 15 and 17 can carry a substantially equal amount of current. In some cases, conductor 15 can carry about 50% of the electrical current between power supply 12 and pump 10, and conductor 17 can carry about 50% of the electrical current between power supply 12 and pump 10. In some cases, conductors 15 and 17 can each carry from about 100 mA to about 700 mA of current.
Any appropriate device can be used to monitor redundant conductors. For example, an appropriate monitor can be a device for measuring electrical current in and determining whether or not the current has increased or decreased. For example, a monitor can be a current transducer, or a semiconductor device that can detect a change in the magnitude of current carried by a conductor, and determine whether the change in current indicates conductor failure. For example, a monitor can be an integrated circuit or an array of integrated circuits. For example, a monitor can include analog signal conditioning and/or digital processing technology.
Monitor 16 can be configured to directly assess the integrity of conductor 17 and indirectly assess the integrity of conductor 15. For example, monitor 16 can be configured to detect a change in current carried by conductor 17, without directly detecting the change in conductor 15, to determine continuity of both conductors 15 and 17. For example, a monitor can detect no change in the magnitude of current carried by conductor 17, indicating that conductor 15 and conductor 17 are continuous conductors. In some cases, a monitor can detect an increase in the magnitude of current carried by conductor 17, indicating that conductor 15 has a discontinuity. In some cases, a monitor can detect a decrease in the magnitude of current in conductor 17, indicating that conductor 17 has a discontinuity. In yet other cases, using the substantially same approach and appropriate circuit logic that would be understood by a person of ordinary skill in the art, a short can also be detected in either of the conductors.
In some cases, a monitor can be configured to detect a change in current carried by conductor 15 and not conductor 17. For example, a monitor can detect no change in the magnitude of current carried by conductor 15, indicating that conductors 17 and 15 are continuous conductors. In some cases, a monitor can detect an increase in the magnitude of current carried by conductor 15, indicating that conductor 17 has a discontinuity. In some cases, a monitor can detect a decrease in the magnitude of current carried by conductor 15, indicating that conductor 15 has a discontinuity. Again, in yet other cases, using the substantially same approach and appropriate logic, a short to other conductors (or each other) or a short to ground can be detected.
A monitor can be configured to detect a change in current carried by a single conductor of a group of redundant conductors. For example, the integrity of a group of three, four, five, or six redundant conductors can be determined by directly monitoring the current flowing in a single conductor of a group. In some cases, a monitor can detect an increase in the magnitude of current flowing in a first conductor, indicating that one or more of a second, third, fourth, or fifth conductor can have a discontinuity.
Any appropriate method can be used to determine a change in the magnitude of current carried by a conductor. For example, the magnitude of current carried by a conductor can be compared to a reference value. The term “reference value” as used herein with respect to the magnitude of current is the current typically found in a fully operational conductor for an electrical device, without defect. For example, a reference value can be any appropriate value for a fully operational conductor, without defect, as determined at the time a device was manufactured, installed, or serviced. In some cases, an appropriate reference value can be determined before a device, such as a blood pump, is implanted. In other cases, the reference value can be determined in real time and/or by comparison to another current measurement. An example of the latter case is when the supply and return current to a load are measured. In the latter cases, this may permit the reference value to be determined based on differences in current consumption changes that may occur during different phases of the cardiac cycle and/or with patient condition (e.g., a VAD may need more current to provide more assistance for patients with weaker hearts). A decrease in the magnitude of current can be any detected value for the magnitude of current carried by a conductor, provided the value is less than a corresponding reference value. For example, a zero value for the magnitude of current carried by a conductor is a decrease in the magnitude of current carried by a conductor of a blood pump system.
An increase in the magnitude of current can be any detected value for the magnitude of current carried by a conductor, provided the value is greater than a corresponding reference value. For example, an increase in the magnitude of current carried by a conductor can be a value of about 1, 0.75, 0.67, 0.50, 0.33, or 0.25 times greater than the reference value. For example, in a pair of redundant conductors, a detected current can be up to about 2× a reference value, if an unmonitored conductor has failed.
With further reference to
In some implementations, the current-sense amplifier 44 includes a current sensor coupled with a signal-conditioning amplifier. The current sensor can be implemented using many techniques. For example, different current sensors include a voltage drop across an in-line resistor, a Hall sensor-based device, or a current transformer. The signal-conditioning amplifier can receive the detected current and condition it for later use. For example, the detected signal can be amplified so that current changes have greater absolute changes and are therefore easier to measure or conform to expected input for subsequent current detection circuitry.
Additionally, or alternatively, monitor 16 can include operational amplifier 46 in some implementations. For example, an appropriate operational amplifier can amplify small signals from current-sense amplifier 44. Operational amplifier 46 can be any appropriate operational amplifiers (e.g., an inverting amplifier, a non-inverting amplifier, a second-order low pass or high pass filter, or a single, dual or quad micropower operational amplifier). Examples of operational amplifiers include, without limitation MAXIM™ MAX4162, MAX4163, and MAX4164, operational amplifiers.
In some cases, monitor 16 can include analog-to-digital (A/D) converter 48. An appropriate A/D converter can be any device for converting analog signal 42 to discrete digital signals. For example, A/D converter 48 can be an integrated circuit. In some cases, a digital signal output can use coding schemes such as binary, Gray code or two's complement binary.
In some cases, monitor 16 can include digital signal processor 50. For example, an appropriate processor can decrypt digital signals from A/D converter 48, and convert the digital signals into information signal 52. For example, processor 50 can compare the magnitude of current detected to a reference value to determine whether the current detected in conductor 17 has increased, indicating a failure of conductor 15, or decreased, indicating a failure of conductor 17, or is unchanged, indicating continuity of conductors 17 and 15.
In some cases, informational signal 52 can be a signal communicating loss of current or conductor failure. In some cases, information signal 52 can be stored and/or communicated to user 54 via message. In some cases, a user can be a blood pump recipient, or a service technician. In some cases, information signal 52 can be transmitted to a system controller. For example, information signal 52 can be processed to trigger an audible alarm, a LED, or an icon on an LCD of a system controller to indicate conductor failure.
Referring to
In some cases, blood pump system 11 can include system controller 18. For example, system controller 18 can receive power from external power supply 12, and distribute power to blood pump 10 via system cables 14. In some cases, system controller 18 can receive signals from monitor 16 for conveying information regarding conductor failure to a blood pump recipient, or a service technician.
Any appropriate blood pump can be used with blood pump systems described herein. For example, an appropriate blood pump can be an electrically-driven pump for providing mechanical circulatory support. For example, external blood pumps (e.g., cardiac bypass devices) and implanted blood pumps (e.g., ventricular assist devices (VADs)) can be appropriate blood pumps.
Any appropriate source of power can be used in a blood pump system provided herein. For example, electrical outlets, external batteries, and implanted batteries, can be appropriate power supplies. External batteries can include a battery pack or packs. For example, a battery pack can carry at least two batteries. In some cases, a battery can be any type of battery required to provide power to a blood pump system. In some cases, a suitable battery can be a primary battery or a rechargeable battery.
Any appropriate cable can be used as a blood pump system cable. For example, an electrical cable or percutaneous cable can be used in a blood pump system described herein. In some cases, a cable can be permanently attached or releasably attached to a device. For example, some cables can feature connectors for releasable attachment to a device.
A blood pump system provided herein can include any appropriate device to command, direct or regulate the activity of components of a blood pump system (e.g., a system controller). In some cases, a system controller can house a monitor for detecting conductor discontinuity as described herein. In some cases, a system controller can house a monitor for each group of redundant conductors. For example, if a system cable included three groups of redundant conductors, a system controller can house an array of three monitors configured to detect a change in current in a single conductor of the group.
Referring to
Referring to
System controller 18 can include control button 34 to access information provided through LCD panel 22. In some cases, a system controller can have up to three control buttons. For example, one button can be pressed to illuminate a battery gauge, and another button can silence an audible alarm. In some cases, simultaneous depression of multiple buttons, or prolonged depression of a single button can actuate hidden and semi-hidden features (e.g., features for setting pump parameters). For example, changing pump speed can be a hidden function accessed by a clinician, or accessed by a recipient with clinician assistance.
Any appropriate LCD screen can be included in a system controller described herein. For example, an appropriate LCD can enable patients and caregivers to attain data on power consumption, pump speed, flow, pulsatility index (i.e., quantification of the oscillations of the arterial blood-flow velocity waveform), pump and system status, and recent event history. In some cases, a LCD can support remote diagnosing. In some cases, data can be accessed through a LCD display by single button control. For example, to view speed setting, flow, pulsatility index, or power, a user can press a display control button, and cycle through read-outs for these data points.
Any appropriate LED can be included in a system controller described herein. In some cases, an LED can be a colored light (e.g., a red, yellow, or green light). In some cases, an appropriate LED can be designed for user-friendly communication (e.g., illuminating an icon). For example, an appropriate LED can provide information regarding battery status, routine maintenance needs, or system failures that require immediate service. In some cases, illumination of an icon can clarify a cause of an audible alarm (e.g., power loss or drive-line disconnection).
A system controller can include multi-sensory alarms. For example, icons, LEDs, auditory signals, and LCD display screen can provide primary and secondary levels of information to users. In some cases, LEDs and audible alarms can provide primary communication of status, alarms, and advisories. For example, red LEDs, in combination with a steady auditory tone, can be used to communicate urgency, and a need for immediate action and response. In some cases, advisories can be communicated through use of yellow LEDs and an audible intermittent tone. In some cases, a display screen can communicate secondary information about alarms, and status for non-routine events.
Referring to
Referring to
System controller 18 can include belt clip 40. A belt-clip can be any appropriate clip for securing a blood pump system controller to a belt worn by a recipient. In some cases, belt-clip 40 can be an articulating belt clip. In some cases, belt clip 40 can be a removable belt clip. In some cases, belt clip 40 can be capable of rotation. For example, belt clip 40 can capable of being rotated at least 180 degrees.
System controller 18 can include attachment site 36. An attachment site can be any part of the housing of a controller that can be secured to a strap or lanyard. Any appropriate strap or lanyard can be attached to an attachment site on a system controller. Appropriate straps can support a system controller and be worn or carried by a blood pump recipient. In some cases, a system controller can have several attachment sites.
This document also provides methods of monitoring the integrity of redundant conductors in a blood pump system. Referring to
In some cases, a detected current can be less than a reference value. For example, if a conductor being directly monitored has failed, the detected current can be less than a reference value. In some cases, a detected current can be greater than a reference value. For example, if one or more indirectly monitored conductors has failed, the detected current in a directly monitored conductor can be greater than a reference value. In some cases, a detected current can be equal to a reference value. For example, if all conductors of a group are continuous, the detected current, in a single conductor being directly monitored, can be substantially equal to the reference value. In some cases, a method provided herein can include continuous monitoring. For example, if there is no change in the current of a conductor being directly monitored, a method can include re-detecting current in a single conductor, until a change is determined. In some cases, information about conductor discontinuity can be communicated to a blood pump user (e.g., a recipient or clinician).
As used herein, the term “monitoring integrity” refers to testing the current flowing in an electrical conductor and determining whether a conductor has been compromised. For example, compromised integrity can be discontinuity due to conductor failure, fracture, or wear. In some cases, compromised integrity can be intermittent, sporadic, or stable.
In some cases, monitoring integrity can refer to determining whether a monitored conductor is carrying excess current. For example, a conductor discontinuity can result in a monitored conductor carrying 0.5, 0.75, or 1 times more current than a conductor would carry if there were no discontinuity. As previously discussed, shorts also can be detected in an analogous fashion. In some cases, monitoring integrity can refer to determining whether a monitored conductor is carrying zero current.
Conductor integrity can be tested or assessed by any technique or device that can detect current and determine whether the current detected is greater than or less than a reference value. For example, the amount of current carried by a single conductor in a group of two or more conductors can be measured using a multimeter, current-sense transducer, or a series of integrated circuits (e.g.,
A reference value can be a value from a previous test of conductor continuity. In some cases, a reference value can be a value determined when a device was manufactured, installed, or serviced. In some cases, a reference value for a medical device (e.g., a VAD) can be a test value detected at the time a device was surgically implanted in a recipient.
In other implementations, the reference value is obtained from a second monitored redundant pair. For instance, current consumption may change during different phases of the cardiac cycle and with patient condition. Thus, the reference value may need to change correspondingly during the cardiac cycle, for each patient, and for different times during the patient's use of the VAD (e.g., the current consumption may decrease if the patient's heart strengthens and is able to move more blood independently). Consequently, the reference value may change also. Obtaining the reference value from a second monitored redundant conductor that is also supplying current to the system provides a reference value that reflects the instant current needs of the system.
A reference value can be used to determine conductor integrity. For example, if a reference value is greater than a test value, the difference indicates a failure in a monitored conductor. In some cases, if a reference value is less than a test value, the difference can indicate a failure of one or more other conductors in a group of redundant conductors. For example, a pair of redundant conductors can carry between about 100 mA and 700 mA. In some cases, a reference value for a conductor of a pair of redundant conductors can be from 100 mA to about 400 mA. In some cases, a test value for a monitored conductor less than 100 mA can indicate a failure, or discontinuity in a monitored conductor. In some cases, a test value for a monitored conductor greater than 400 mA can indicate a failure in an unmonitored conductor.
The methods described herein can be used to monitor the integrity of redundant conductors. For example, a group of redundant conductors can be two or more conductors that share current load of a circuit. For example, each conductor in a pair of conductors can carry about 50% of the current load of a circuit. A group of redundant conductors can include two, three, four, or more conductors in a group of redundant conductors. For each group of redundant conductors, each conductor of a group can carry a substantially equal share of the current carried by the group. For example, a conductor of a group of three, four, five, or six redundant conductors can carry about 33%, 25%, 20%, or 17% of the current carried by a group of redundant conductors.
In some cases, information about conductor integrity can be provided to a user. For example, information about conductor continuity/discontinuity can be communicated to a blood pump recipient, a clinician, or a service technician. In some cases, information can be communicated through a system controller, via an audible or visual alarm. In some cases, information about conductor continuity can be stored in an event log in a system controller, and displayed on an LCD screen. In some cases, the information provided can display details about a discontinuity (e.g., whether the integrity of a monitored conductor or an unmonitored conductor has been compromised.)
It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.
This application is a continuation of U.S. application Ser. No. 12/472,812, entitled “MONITORING OF REDUNDANT CONDUCTORS,” filed May 27, 2009, now U.S. Pat. No. 9,782,527, the full disclosure of which is incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
3097366 | Winchell | Jul 1963 | A |
4068105 | Jain et al. | Jan 1978 | A |
4199029 | Marek | Apr 1980 | A |
4227145 | Bonikowski et al. | Oct 1980 | A |
4888011 | Kung et al. | Dec 1989 | A |
5250894 | Bridges et al. | Oct 1993 | A |
5325062 | Bachand et al. | Jun 1994 | A |
5332973 | Brown et al. | Jul 1994 | A |
5345180 | Maier et al. | Sep 1994 | A |
5613935 | Jarvik | Mar 1997 | A |
5652506 | Sorenson et al. | Jul 1997 | A |
5713954 | Rosenberg et al. | Feb 1998 | A |
5725357 | Nakazeki et al. | Mar 1998 | A |
5733313 | Barreras, Sr. et al. | Mar 1998 | A |
5894273 | Meador et al. | Apr 1999 | A |
5904646 | Jarvik | May 1999 | A |
5947703 | Nojiri et al. | Sep 1999 | A |
5947892 | Benkowski et al. | Sep 1999 | A |
6137416 | Meador | Oct 2000 | A |
6146325 | Lewis et al. | Nov 2000 | A |
6149683 | Lancisi et al. | Nov 2000 | A |
6227797 | Watterson et al. | May 2001 | B1 |
6234772 | Wampler et al. | May 2001 | B1 |
6264601 | Jassawalla et al. | Jul 2001 | B1 |
6264635 | Wampler et al. | Jul 2001 | B1 |
6278251 | Schöb et al. | Aug 2001 | B1 |
6468041 | Ozaki | Oct 2002 | B2 |
6575717 | Ozaki et al. | Jun 2003 | B2 |
6589030 | Ozaki | Jul 2003 | B2 |
6605032 | Benkowski et al. | Aug 2003 | B2 |
6626644 | Ozaki | Sep 2003 | B2 |
6688861 | Wampler | Feb 2004 | B2 |
6707200 | Carroll et al. | Mar 2004 | B2 |
6736770 | Leysieffer et al. | May 2004 | B2 |
6817836 | Nose et al. | Nov 2004 | B2 |
6949066 | Bearnson et al. | Sep 2005 | B2 |
6969345 | Jassawalla et al. | Nov 2005 | B2 |
7138776 | Gauthier et al. | Nov 2006 | B1 |
7150711 | Nüsser et al. | Dec 2006 | B2 |
7229474 | Hoffmann et al. | Jun 2007 | B2 |
7239098 | Masino | Jul 2007 | B2 |
7284956 | Nose et al. | Oct 2007 | B2 |
7462019 | Allarie et al. | Dec 2008 | B1 |
7497116 | Miyakoshi et al. | Mar 2009 | B2 |
7511443 | Townsend et al. | Mar 2009 | B2 |
7563225 | Sugiura | Jul 2009 | B2 |
7591777 | LaRose et al. | Sep 2009 | B2 |
7645225 | Medvedev et al. | Jan 2010 | B2 |
7699588 | Mendler | Apr 2010 | B2 |
7854631 | Townsendl et al. | Dec 2010 | B2 |
7861582 | Miyakoshi et al. | Jan 2011 | B2 |
7887479 | LaRose et al. | Feb 2011 | B2 |
7951062 | Morello | May 2011 | B2 |
7976271 | LaRose et al. | Jul 2011 | B2 |
8157720 | Marseille et al. | Apr 2012 | B2 |
8303482 | Schima et al. | Nov 2012 | B2 |
8382830 | Maher et al. | Feb 2013 | B2 |
8506470 | LaRose et al. | Aug 2013 | B2 |
8517699 | Horvath | Aug 2013 | B2 |
8556795 | Bolyard et al. | Oct 2013 | B2 |
8597350 | Rudser et al. | Dec 2013 | B2 |
8764621 | Badstibner et al. | Jul 2014 | B2 |
8870739 | LaRose et al. | Oct 2014 | B2 |
8882477 | Fritz, IV et al. | Nov 2014 | B2 |
8956275 | Bolyard et al. | Feb 2015 | B2 |
9782527 | Thomas et al. | Oct 2017 | B2 |
20030069465 | Benkowski et al. | Apr 2003 | A1 |
20070142696 | Crosby et al. | Jun 2007 | A1 |
20070229295 | Curt et al. | Oct 2007 | A1 |
20080319544 | Yaegashi | Dec 2008 | A1 |
20100004761 | Flanders et al. | Jan 2010 | A1 |
20100130809 | Morello | May 2010 | A1 |
20100241223 | Lee et al. | Sep 2010 | A1 |
20100305692 | Thomas et al. | Dec 2010 | A1 |
20100327687 | Iannello et al. | Dec 2010 | A1 |
20110071337 | Thompson et al. | Mar 2011 | A1 |
20110237863 | Ricci et al. | Sep 2011 | A1 |
20110313237 | Miyakoshi et al. | Dec 2011 | A1 |
20120016178 | Woodard et al. | Jan 2012 | A1 |
20120226097 | Smith et al. | Sep 2012 | A1 |
20120245681 | Casas et al. | Sep 2012 | A1 |
20130331934 | Kabir et al. | Dec 2013 | A1 |
20140100413 | Casas et al. | Apr 2014 | A1 |
20140194985 | Vadala, Jr. | Jul 2014 | A1 |
20140275723 | Fritz, IV et al. | Sep 2014 | A1 |
20140303426 | Kerkhoffs et al. | Oct 2014 | A1 |
20140357937 | Reyes et al. | Dec 2014 | A1 |
20150051438 | Taskin | Feb 2015 | A1 |
Number | Date | Country |
---|---|---|
2006167142 | Jun 2006 | JP |
2008202974 | Sep 2008 | JP |
1995028185 | Oct 1995 | WO |
9618358 | Jun 1996 | WO |
9808564 | Mar 1998 | WO |
1999017819 | Apr 1999 | WO |
2002032478 | Apr 2002 | WO |
2007053881 | May 2007 | WO |
2008154387 | Dec 2008 | WO |
Entry |
---|
U.S. Appl. No. 12/472,812 , “Advisory Action”, dated Jan. 3, 2012, 3 pages. |
U.S. Appl. No. 12/472,812 , “Final Office Action”, dated Oct. 28, 2011, 13 pages. |
U.S. Appl. No. 12/472,812 , “Final Office Action”, dated Jul. 16, 2015, 9 pages. |
U.S. Appl. No. 12/472,812 , “Non-Final Office Action”, dated Dec. 26, 2014, 12 pages. |
U.S. Appl. No. 12/472,812 , “Non-Final Office Action”, dated Apr. 15, 2011, 13 pages. |
AU2010253836 , “Examination Report No. 1”, dated Sep. 28, 2012, 3 pages. |
JP2012-513263 , “Office Action”, dated May 14, 2013, 3 pages. |
JP2014-034767 , “Office Action”, dated Feb. 3, 2015, 2 pages. |
JP2014-034767 , “Office Action”, dated Jun. 23, 2015, 2 pages. |
PCT/US2010/036439 , “International Preliminary Report on Patentability”, dated Dec. 8, 2011, 8 pages. |
PCT/US2010/036439 , “International Search Report and Written Opinion”, dated Sep. 27, 2010, 10 pages. |
Number | Date | Country | |
---|---|---|---|
20150250936 A1 | Sep 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12472812 | May 2009 | US |
Child | 14719045 | US |